Trial
NCT02745756
A Combined Cell Therapy Approach to the Treatment of Neuroblastoma
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Collaborators
Johns Hopkins All Children's Hospital
Condition
Neuroblastoma
Intervention
Autologous Hematopoietic Progenitor Cell Transplant
Why stopped
no enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-08-30